233 related articles for article (PubMed ID: 26582492)
1. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
2. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
3. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic value of screen detection in invasive breast cancer.
Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
[TBL] [Abstract][Full Text] [Related]
5. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
[TBL] [Abstract][Full Text] [Related]
7. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
[TBL] [Abstract][Full Text] [Related]
8. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
9. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
[TBL] [Abstract][Full Text] [Related]
10. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
11. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
12. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
[TBL] [Abstract][Full Text] [Related]
13. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
14. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
Moshina N; Backmann HA; Skaane P; Hofvind S
Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
[TBL] [Abstract][Full Text] [Related]
15. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
16. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
[TBL] [Abstract][Full Text] [Related]
17. Tumour-related factors and prognosis in breast cancer detected by screening.
Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
[TBL] [Abstract][Full Text] [Related]
18. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
19. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
20. Breast density and breast cancer-specific survival by detection mode.
van der Waal D; Verbeek ALM; Broeders MJM
BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
